ODELIA at ECR 2026: Advancing Trustworthy AI for Cancer Care
At ECR 2026, the session “Novel approaches for trustworthy artificial intelligence (AI) in cancer diagnostics and treatment” will bring together leading experts to explore how
Empowering secure and collaborative AI-driven healthcare through swarm learning, revolutionizing diagnostics, and fostering global cooperation
Our focus is on harnessing AI for breast cancer detection in MRI screenings, serving as a model for further advancements using swarm learning. We will accelerate AI development, improve diagnostic performance, and promote generalizable solutions, while also protecting privacy and fostering collaboration, ultimately contributing to better healthcare outcomes for European patients.
Uniting institutions for secure, collaborative AI development without data sharing, protecting privacy and promoting true democratic participation.
Developing and validating cutting-edge AI algorithms to accurately identify breast cancer in MRI screenings, saving lives and improving patient care.
Enhancing diagnostic performance and creating robust, generalizable solutions for better healthcare outcomes, enabled by the swarm learning approach.
Engaging opinion leaders, fostering collaboration, and initiating follow-up projects to expand the potential and reach of swarm learning in healthcare.
ODELIA is a unique and groundbreaking project that harnesses the power of swarm learning to revolutionize medical AI in a privacy-preserving and democratic way. With the first open source pan-European swarm learning network, we aim to develop and validate AI algorithms for breast cancer detection in MRI screening examinations, and paving the way for numerous other clinical applications.
To ensure the project’s success and deliver its transformative results, ODELIA is structured into eight distinct work packages, each focusing on specific tasks and objectives. These work packages cover everything from creating a minimum viable product to addressing regulatory frameworks and fostering communication among stakeholders. By breaking down the project into manageable components, ODELIA is poised to make a lasting impact on the medical AI landscape and improve healthcare outcomes for patients across Europe.
At ECR 2026, the session “Novel approaches for trustworthy artificial intelligence (AI) in cancer diagnostics and treatment” will bring together leading experts to explore how
Early detection of breast cancer remains one of the most critical factors in improving patient outcomes. Magnetic Resonance Imaging (MRI) is increasingly used alongside mammography,
The ODELIA consortium gathered in Barcelona on 15–16 September for its annual meeting, hosted by the Vall d’Hebron Institute of Oncology (VHIO). Members reflected on
We are delighted to announce the programme and final decisions for the Deep-Breath Workshop, which will be held on 23 September 2025 in Daejeon, South
The ODELIA Consortium brings together a diverse and talented team of experts from across Europe. Comprising 12 partners from 7 countries, our consortium represents a multidisciplinary collaboration of specialists in the fields of medicine, artificial intelligence, and big data. With our strong collaborative spirit and dedication to innovation, we are working together to transform the landscape of medical AI and advance data privacy through swarm learning.